Could a mild zap to the brain help you find your words?

NCT ID NCT05386394

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase II trial tests whether a safe, non-invasive brain stimulation technique called tDCS, combined with language therapy, can improve word-finding in people with primary progressive aphasia (PPA). The study enrolls 180 adults aged 50–90 with certain types of PPA. Participants receive either real or sham tDCS during therapy sessions, and researchers measure changes in speaking accuracy right after treatment and again three months later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) — a gentle electrical current applied to the brain
What this could lead to
If it works, this could provide a safe, at-home-usable treatment to help people with primary progressive aphasia speak and name objects more accurately.
What could go wrong
This is a mid-stage trial with 180 participants, so results are not yet proven. The improvement may be small or not last long, and not everyone may benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOGOPENIC PROGRESSIVE APHASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baycrest Centre for Geriatric Care

    RECRUITING

    Toronto, Ontario, M6A 2E1, Canada

  • Johns Hopkins Hospital

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.